Short Interest in NeuBase Therapeutics, Inc. (NASDAQ:NBSE) Drops By 53.9%
NeuBase Therapeutics, Inc. (NASDAQ:NBSE – Get Free Report) was the recipient of a significant decrease in short interest in October. As of October 31st, there was short interest totalling 8,900 shares, a decrease of 53.9% from the October 15th total of 19,300 shares. Based on an average trading volume of 2,280,000 shares, the days-to-cover ratio […]